Cargando…

Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin

Cancer-induced blood coagulation in human tumour generates insoluble fibrin (IF)-rich cancer stroma in which uneven monoclonal antibody (mAb) distribution reduce the potential effectiveness of mAb-mediated treatments. Previously, we developed a mAb that reacts only with IF and not with fibrinogen (F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuchigami, Hirobumi, Manabe, Shino, Yasunaga, Masahiro, Matsumura, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155080/ https://www.ncbi.nlm.nih.gov/pubmed/30242282 http://dx.doi.org/10.1038/s41598-018-32601-0

Ejemplares similares

Characterization of antibody clones that bind exclusively to insoluble fibrin
por: Fuchigami, Hirobumi, et al.
Publicado: (2023)

Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment
por: Obonai, Toshifumi, et al.
Publicado: (2016)

Discovery of an uncovered region in fibrin clots and its clinical significance
por: Hisada, Yohei, et al.
Publicado: (2013)

A Novel and Potent Thrombolytic Fusion Protein Consisting of Anti-Insoluble Fibrin Antibody and Mutated Urokinase
por: Hanaoka, Shingo, et al.
Publicado: (2021)

Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease
por: Yasunaga, Masahiro, et al.
Publicado: (2017)

Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015)

Imaging mass spectrometry for the precise design of antibody-drug conjugates
por: Fujiwara, Yuki, et al.
Publicado: (2016)

Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019)

Development of Antibody–Drug Conjugates Using DDS and Molecular Imaging
por: Yasunaga, Masahiro, et al.
Publicado: (2017)

Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2015)

Platelet Counts in Insoluble Platelet-Rich Fibrin Clots: A Direct Method for Accurate Determination
por: Kitamura, Yutaka, et al.
Publicado: (2018)

Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
por: Page, Martin J., et al.
Publicado: (2019)

Multiscale Network Modeling of Fibrin Fibers and Fibrin Clots with Protofibril Binding Mechanics
por: Yesudasan, Sumith, et al.
Publicado: (2020)

On the Germinal Matter of the Blood, with Remarks upon the Formation of Fibrin
por: Beale, Lionel S.
Publicado: (1866)

Antibody–drug conjugates: Recent advances in payloads
por: Wang, Zhijia, et al.
Publicado: (2023)

Specific binding of soluble fibrin to macrophages
Publicado: (1977)

Facile protein conjugation of platinum for light-activated cytotoxic payload release
por: Imberti, Cinzia, et al.
Publicado: (2021)

Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release
por: Quintana, Jeremy M., et al.
Publicado: (2022)

THE ENZYMES OF FIBRINOUS EXUDATES—THE EFFECT OF ONE ENZYME UPON ANOTHER
por: Barker, Bertha I.
Publicado: (1908)

ET-05 PRECLINICAL STUDY OF AN ANTI-HUMAN TISSUE FACTOR ANTIBODY-DRUG CONJUGATE IN A MALIGNANT GLIOMA XENOGRAFT MODEL
por: Takashima, Hiroki, et al.
Publicado: (2019)

Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins
por: Zhou, Qun
Publicado: (2023)

THE ENZYMES OF FIBRIN
por: Barker, Bertha I.
Publicado: (1908)

A review of fibrin and fibrin composites for bone tissue engineering
por: Noori, Alireza, et al.
Publicado: (2017)

Antibody-Drug Conjugates Containing Payloads from Marine Origin
por: Cheng-Sánchez, Iván, et al.
Publicado: (2022)

Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network
por: Whyte, Claire S., et al.
Publicado: (2016)

Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking
por: Buitrago, Lorena, et al.
Publicado: (2021)

Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma(☆)
por: Chung, Eun Ji, et al.
Publicado: (2013)

FITC-Dextran Release from Cell-Embedded Fibrin Hydrogels
por: Lepsky, Viki Raz, et al.
Publicado: (2021)

Fibrin glue in ophthalmology
por: Kumar, Niranjan, et al.
Publicado: (2010)

Fibrin glue in ophthalmology
por: Panda, Anita, et al.
Publicado: (2009)

Fibrinous Coagula in the Heart
por: Roy, G. C.
Publicado: (1883)

On the Etiology of Fibrinous Bronchitis
por: Ritchie, W. T.
Publicado: (1904)

On Fibrinous Deposition in the Heart
Publicado: (1863)

Fibrinous Coagula in the Heart
Publicado: (1864)

On the Physiological Position of Fibrin
por: Joynes, Levin S.
Publicado: (1859)

Fibrin clot and Leukocyte-rich platelet-rich fibrin show similar release kinetics and amount of growth factors: a pilot study
por: Nakanishi, Yuta, et al.
Publicado: (2023)

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
por: Kołodziejczyk, Joanna, et al.
Publicado: (2013)

Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency
por: Su, Dian, et al.
Publicado: (2021)

Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody–Drug Conjugates
por: Karpov, Alexei S., et al.
Publicado: (2018)

Payload diversification: a key step in the development of antibody–drug conjugates
por: Conilh, Louise, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5rr3752uublmkdg09q65mhvqne